Ultrasound Transducer Market Worth $4.2 Billion By 2026

The global ultrasound transducer market size is anticipated to reach USD 4.2 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.6% during the forecast period. Increasing number of product launches and growing focus of the major players on innovations for safe and accurate diagnosis are the factors driving the growth.

North America is anticipated to hold substantial share of the market during the forecast period owing to high adoption of advanced medical devices. Continuous innovations in ultrasound machine such as portable and mobile ultrasound machine is expected to fuel the growth. Moreover, presence of a large number of ultrasound transducer manufacturers is anticipated to bode well for the regional growth. These companies emphasize on heavy investments to develop smart production methods and process automation, which is a key factor in optimizing product prices and maximizing revenues.

Another innovation pertaining to these devices include burst wave lithotripsy which help delicate procedures including kidney stone destruction. The technology is not only efficient but also offers non-invasive procedure to patients, which is anticipated to ultimately augment the product demand in the forthcoming years.

Growing number of partnerships between resellers for ultrasound transducers is an emerging trend witnessed in the market. Direct purchase from Original Equipment Manufacturers (OEMs) is another trend observed in the market. End users are increasingly dealing with OEMs since they offer efficient technologies like custom strain gauge sensing to finished product designs, to achieve greater business advantage.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/ultrasound-transducer-market

Further key findings from the report suggest:

  • Convex transducers holds largest market share owing to the advantages of the product such as superior quality resolution for accurate diagnosis, wider footprint, and ergonometric designs
  • 2D linear transducers are highly preferred as compared to 3D linear owing as they provide detailed results in heart conditions
  • General imaging segment is expected to lead the ultrasound transducer market in the forthcoming years owing to increased adoption of ultrasound devices in primary diagnostic purposes
  • Owing to lower labor costs and untapped areas in developing regions of Asia Pacific, the market players are expected to witness huge opportunities to increase their clientele and expand their product portfolio
  • Key players in the ultrasound transducers market include Shenzhen Ruqi Technology, GE Healthcare, Siemens Healthineers, Samsung Medison, Hitachi, Esaote, Mindray, SIUI, , SonoScape Medical, FUJIFILM SonoSite, Shenzhen Jiarui Electronic Technology, and Koninklijke Philips N.V.

Medical Device Validation & Verification Market Worth $1.1 Billion By 2027

The global medical device validation and verification market size is expected to reach USD 1.1 billion by 2027, expanding at a CAGR of 11.1% over the forecast period, according to a new report by Grand View Research, Inc.

Increase in demand for advanced and quality medical products and rising complexity with respect to product designing and engineering are anticipated to boost market growth. Rapid innovations in healthcare have increased the need for companies to incorporate new technologies and software applications in their products to meet the demand for validation and verification. Increase in product complexity, availability of newer types of material, and high risk of product failures are some of the key factors increasing the need for validation and verification services.

North America dominated the global medical device validation and verification market, accounting for 44.88% share of the overall revenue in 2019. Rapid growth in manufacturing of medical devices to meet high demand for efficient healthcare services, including validation and verification, is one of the major factors contributing to the regional market growth. In addition, stringent regulatory environment in U.S. is fueling market growth in the region.

Asia Pacific is anticipated to expand at a CAGR of 12.1% during the forecast period. This can be attributed to increased opportunities for players, especially in Japan, China, and India, improved regulatory framework, and increase in the number of medical devices companies.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/medical-device-verification-validation-market

Further key findings from the study suggest:

  • Based on therapeutic area, oncology held the largest market share in 2019 and is expected to witness lucrative growth during the forecast period due to increasing prevalence of cancer worldwide
  • On the basis of application, the diagnostic segment held the largest share of 44.16% in 2019 due to increasing demand for diagnostic technology in healthcare to identify the cause of disease
  • The therapeutic application segment is projected to register the fastest growth during the forecast period due to rising prevalence of chronic diseases
  • North America dominated the medical device validation and verification market and accounted for a share of 44.88% in 2019. This is attributed to rapid growth in manufacturing of medical devices to meet high demand for efficient healthcare services, including validation and verification
  • Asia Pacific is anticipated to expand at a CAGR of 12.1% during the forecast period. This can be attributed to increased opportunities for players, especially in Japan, China, and India, and improved regulatory framework.

Catheter Market Size Worth $77.7 Billion By 2026

The global catheter market size is expected to reach USD 77.7 billion by 2026 registering a CAGR of 9.7%, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases and supportive insurance policies are some of the prime factors boosting the market growth. Presence of multi-national manufacturers and improving medical facilities, especially across developing regions, are also anticipated to propel the market growth over the forecast period.

As per the statistics published by the WHO, chronic diseases is anticipated to contribute to 73% of all deaths and 60% of the global burden of disease by 2020. The rise in geriatric population has also led to increase in number of hospitalizations and surgeries anticipating the market growth. Catheters have undergone technological advancements; for instance, miniaturized products and introduction of antimicrobial catheters to reduce associated infections. Wide usage of minimally invasive surgeries is expected to favor the market growth.

Rising awareness about catheters has in turn boosted their demand. In addition, increasing number of midscale catheter manufacturers gaining a higher market share is expected to promote the market growth. Furthermore, rise in funding by various government bodies and medical device manufacturers for R&D will boost the market growth. However, requirement of intensive capital for the development of advanced devices may obstruct market development.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis

Further key findings from the study suggest:

  • The cardiovascular product segment led the market in 2018 owing to increase in the number of patients suffering from chronic Cardiovascular Diseases (CVDs)
  • Specialty catheters is expected to be the fastest-growing product segment over the forecast period due to rising prevalence of target diseases and demand for minimally invasive procedures
  • Asia Pacific is anticipated to witness the fastest CAGR from 2019 to 2026 owing to rising cases of kidney and cardiovascular diseases, improving medical facilities, and supportive insurance policies
  • Some of the key companies in the global catheter market are Medtronic Plc.; Convatec Corp.; Smiths Medical, Inc.; Boston Scientific Corp.; and Coloplast A/S
  • The market is price-sensitive with many small-, medium-, and large-scale companies. Key companies focus on product bundling strategies
  • Strategic partnerships between the manufacturers and the healthcare establishments intensify the market competition

3D Ultrasound Market Size Worth $4.8 Billion By 2027

The global 3D ultrasound market size is expected to reach USD 4.8 billion by 2027, expanding at a CAGR of 6.6%, according to a new report by Grand View Research, Inc. Increasing preference for noninvasive diagnostic procedures coupled with continuous technological advancement in the field of 3D imaging is contributing to market growth. The advent of Artificial Intelligence (AI) and machine learning have improved the patient outcome.

AI can conduct a quantitative assessment by analyzing imaging information automatically and produce precise imaging diagnosis. The potential use of AI technology in the 3D ultrasound pipeline includes image and data interpretation, multi transducer technologies, image navigation, and quality optimization. Moreover, rising usage of imaging technology in various applications such as cardiology, general imaging, gynecology, and point of care are also contributing to market growth.

The market is expected to witness high demand for point of care 3D ultrasound. Major factors contributing to the growth are a miniaturization of technology and lower system cost. Furthermore, an increasing number of product launches and continuous technological collaboration among major players in the industry are also boosting the market growth. For instance, in November 2019, Philips Launched EPIQ Elite ultrasound system for gynecology and general imaging. The device combines 3D and 4D imaging and would improve patients’ clinical outcomes.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/3d-ultrasound-market

Further key findings from the study suggest:

  • Based on the application, the general imaging segment dominating the market owing to the increasing number of product launches
  • Based on end-use, the handheld segment is expected to grow at the fastest pace over the forecast period due to the rise in point of care facilities
  • North America was the leading regional segment in 2019 and is expected to maintain its position during the forecast period, owing to the presence of various market leaders and continuous technological advancement in the region.

Medical X-Ray Generator Market Worth $2.07 Billion By 2024

The global medical X-ray generator market is expected to reach USD 2.07 billion by 2024, according to a new report by Grand View Research, Inc. The unprecedented shift in lifestyle associated habits coupled with increasing prevalence chronic diseases, is responsible for the rise in demand for accurate diagnostic tools, which is presumed to bolster the market growth. In addition, global geriatric population base that is highly susceptible toward developing these chronic diseases is anticipated to impel the demand for high resolution imaging systems. This high requirement is effectively addressed by use of the medical x-ray generators, thus presenting the market with high growth potential throughout the forecast period.

In addition, these devices lead to better patient outcomes, which include faster detection of disease conditions, and improved patient safety profile. These associated benefits are expected to increase the overall adoption rate of these medical x-ray generators over the coming years

Furthermore, technological advancements such modification of the design of computer-controlled x-ray generator interface with imaging system results in better synchronization of the overall imaging system with x-ray generators. This has resulted in application of medical x-ray generators in fluoroscopy, radiography, and angiography, thus widening the potential for growth during the forecast period.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/medical-x-ray-generator-market

Further Key Findings from the Study Suggest:

  • Stationary medical x-ray generators held the largest share of over 68.0% in the product segment in 2015. The dominant share can be attributed to low costs, high stability, and durability associated with the device, which is responsible for the high adoption rate in hospital settings.
  • Cardiovascular segment held the substantial share of over 20.0% in the application segment in 2015. The aforementioned is primarily a consequence of increasing prevalence of cardiovascular diseases. In addition, high demand for mono energetic x-ray generators for cardiovascular imaging, owing to its appropriate and safe intensity of energy projections, is presumed to provide growth potential to the Medical X-ray Generator Market. 
  • In 2015, North America held a substantial share of the overall Medical X-ray Generator Market at over 30.0%. The presence of government regulatory authorities, consistently striving toward high patient safety is a significant factor that is presumed to be responsible for the largest market share of this region. 
  • Furthermore, frequent product launch by prominent market players in the U.S. is presumed to be responsible for its largest share. For instance, In June 2015, Spellman High Voltage Electronics Corporation launched new range of radiography generators, Z series X-ray Generators. The product was launched at a relatively lower cost to cater to mid-tier medical radiography and veterinary imaging segments. 
  • Some key players are increasingly involved in entering into collaborations and product launches to garner a larger share. For instance, in April 2015, Emd Technologies, Inc., launched a new range of EPS Unipolar High-Voltage Generators in the area of the mammography radiology segment. Moreover, in March 2015, Spellman announced to expand x-ray source product portfolio, through the launch of Monoblock x-ray sources with the introduction of XRBC Monoblock series.

Stethoscope Market Size Worth $593.4 Million By 2027

The global stethoscope market size is anticipated to reach USD 593.4 million by 2027, expanding at a CAGR of 4.9%, according to a new report by Grand View Research, Inc. Growing prevalence of cardiovascular and respiratory disorders, and increasing geriatric population are driving the market. Increase in incidence of numerous cardiovascular and pulmonary diseases in several countries is anticipated to impact market growth over the forecast period. Stethoscope is widely used for heart auscultation (listening to the heart sound) during diagnosis of cardiac illness. It is also used to primarily examine the condition of phlegm in the respiratory tract.

Moreover, growing elderly population has increased the demand for the medical device for the primary diagnosis of numerous chronic health ailments. According to the CDC, people aged above 65 years are at a higher risk of developing several chronic diseases. In addition, the world population aged 60 years and above is expected to increase from 900 million in 2015 to 2 billion in 2050 from. This is expected to boost the market.

Furthermore, several government initiatives, the introduction of new products, and incorporation of new technologies by market players, are likely to boost the market during the forecast period. For instance, 3M has launched ‘Single-Patient Stethoscope’ to overcome the issues related to disposable stethoscopes such as, inadequate audibility and discomfort faced by healthcare professionals. The device helps in minimizing the risk of cross-contamination while enhancing patient care.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/stethoscopes-market

Further key findings from the report suggest:

  • In terms of revenue, the teaching type segment dominated the market in 2019. The device is widely used for teaching/training purposes and is ideal for instructors and medical students
  • The electronic type segment is expected to witness the highest CAGR of 5.5% from 2020 to 2027 owing to advanced features offered by the medical device such as, electronically amplified sound quality, audio recording, and reduced background noises for improved diagnosis
  • North America dominated the market with the highest revenue share in 2019 owing to the presence of well-established healthcare facilities and increasing prevalence of numerous heart and lung associated diseases
  • In Latin America, the market is expected to witness the highest CAGR of 5.3% from 2020 to 2027 due to increasing healthcare expenditure in most of the countries in the region.

Transdermal Drug Delivery System Market Worth $81.4 Billion By 2024

The global transdermal drug delivery system market is expected to reach USD 81.4 billion by 2024, according to a new report by Grand View Research, Inc. The unprecedented global shift in the adoption of unhealthy lifestyles is presumed to be responsible for the high prevalence of chronic diseases, such as cancer and diabetes, which is expected to drive the clinical urgency to incorporate transdermal drug delivery systems in the future treatments. Moreover, the rising geriatric population base, which is highly susceptible to developing the aforementioned chronic diseases are expected to propel the demand for highly efficacious pharmacological drugs. 

The market is driven by technological advancements in transdermal drug delivery devices, which is anticipated to serve the market with future growth opportunities. These advancements include advanced, third-generation, transdermal drug delivery technologies including iontophoresis, ultrasound, and microneedles or mechanical arrays. These technologies serve as effective transdermal drug diffusion alternatives that are capable of improving overall patient health and quality of life. For instance, the advent of matrix-controlled transdermal drug diffusion comprising a drug reservoir and a thermo effector enhances skin permeation and enables controlled drug delivery.  

Click the link below:
http://www.grandviewresearch.com/industry-analysis/transdermal-drug-delivery-systems-industry

Further key findings from the study suggest:

  • The cardiovascular application segment is expected to exhibit growth at a significant CAGR of over 12.0% during the forecast period. This is a consequence of the high clinical urgency to curb hypertension and the need for precise drug delivery at a constant rate, which has led to the development of transdermal drug delivery systems.
  • The mechanical array in the technology segment is anticipated to witness an exponential CAGR of over 12.5%. The lucrative growth is attributed to the availability of different forms of microneedle transdermal systems, such as solid, hollow, and dissolving microneedles, as per the suitability and needs of the patients.
  • In 2015, North America dominated the overall Transdermal Drug Delivery System Market at over 50.0%. The consistent number of product launches being undertaken and the continual participation of the prominent players in conducting clinical trials are anticipated to promote the incorporation of transdermal drug delivery systems.
  • The key players are increasingly involved in initiating collaborative strategies and frequent product launches to capture a larger market share. For instance, in September 2014, Noven Pharmaceuticals, Inc. received FDA approval for Minivelle, estradiol transdermal system to be used for the prevention of postmenopausal osteoporosis. Furthermore, in June 2015, Boehringer Ingelheim GmbH sponsored the clinical trials, which investigated the bioequivalence of transdermal clonidine administration.

Aqua Gym Equipment Market Size Worth $722.3 Million By 2025

The global aqua gym equipment market size is expected to reach USD 722.3 million by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 5.01% during the forecast period. Growing consumer awareness regarding healthy lifestyle and physical appearances.

Rising pressure of hectic lifestyles among leads to serious health conditions such as high or low blood pressure, diabetes, and obesity to name a few. Aqua gym can reduce these problems as the workouts help reduce tension and also serve as a relaxing activity. Water gym also provides resistance as people move through it, which allows to work out vigorously with little chance of injury. Elderly prefer water fitness due to less probability of injuries. The exercise also helps cure hip and knee joint problems, especially among geriatric population.

Strength training aqua gym equipment category is expected to register the fastest CAGR of 6.24% from 2015 to 2025. The major reason people prefer aqua gym is its quick strength gaining procedures. It helps the muscles to get a rigid workout. It has been observed that 12 weeks of regular water gym training can provide significant gains in agility, strength, and flexibility. The quick fitness process associated with strength training is expected to drive growth of the global market.

North America is the largest market for aqua gym equipment. In 2018, it accounted for more than 40% of the global market. Gradually increasing health consciousness among a large number of U.S. population is anticipated to bode well for regional growth. Sales of floating fitness mats and water cycling has increased due to rising customers across the country. As per a New York based aqua fitness company AQUASTUDIO, aqua cycling has the ability to burn up to 600 calories in one hour.

The aqua gym equipment market is competitive in nature with the presence of many small and large players. Some of the major companies are PlayCore, Inc.; AquaJogger; Acquapole sas; TEXAS REC; Hydro Fit Inc.; BECO-Beermann GmbH & Co. KG; Be Aqua Pte Ltd; Aqua Gear Inc.; HydroWorx International, Inc.; and others. Equipment manufacturers are working on product innovation and development to attract more customers. Weight loss product manufacturer VACUACTIVUS has launched five aqua weight loss equipment to get aqua gym customer base in the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/aqua-gym-equipment-market

Further key findings from the report suggest:

  • In terms of revenue, strength training equipment is projected to ascend at a CAGR of 6.24% from 2019 to 2025
  • Cardiovascular equipment held the leading market share of 60.45% in 2018
  • North America led with 40.1% share of the global aqua gym equipment market in 2018
  • Asia Pacific is anticipated to witness significant growth with increasing disposable income in India, South Korea, China, and Japan
  • Key market players include PlayCore, Inc.; AquaJogger; Acquapole sas; TEXAS REC; Hydro Fit Inc.; BECO-Beermann GmbH & Co. KG; Be Aqua Pte Ltd; Aqua Gear Inc.; and HydroWorx International, Inc.
  • The market is highly competitive in nature. Manufacturers are concentrating on new product launches and technological innovation to estimate existing and future demand patterns from upcoming market.